Project Details
Description
AN OPEN-LABEL, RANDOMIZED, ADAPTIVE, TWO-ARM, MULTICENTER TRIAL TO EVALUATE PHARMACOKINETICS AND PHARMACODYNAMICS OF TWO DOSES OF OSELTAMIVIR (TAMIFLU) IN THE TREATMENT OF INFLUENZA IN IMMUNOCOMPROMISED CHILDREN LESS THAN 13 YEARS OF AGE, WITH
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/16 → 6/30/20 |
Funding
- HOFFMANN-LA ROCHE PHARMACEUTICALS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.